Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Jul;35(7):950–954. doi: 10.1136/gut.35.7.950

Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention.

P M Choi 1, M P Zelig 1
PMCID: PMC1374843  PMID: 8063223

Abstract

Colorectal cancer is the most frequent malignant complication in patients with inflammatory bowel disease. Eighty patients with colorectal cancer complicating Crohn's disease (CD) or ulcerative colitis (UC) with median ages at diagnosis of colorectal cancer of 54.5 years and 43.0 years respectively were studied. The median duration of disease to the diagnosis of cancer was long (CD 15 years; UC 18 years). Most cancers developed after more than eight years of disease (CD 75%; UC 90%). Patients with multiple carcinomas at diagnosis were equally common (CD 11%; UC 12%). Carcinoma occurred in the area of macroscopic disease in most patients (CD 85%; UC 100%). Mucinous and signet ring histological features were equally common (CD 29%; UC 21%). Dysplasia was present with similar frequency in both diseases (CD 73%; UC 79%). The overall five year survival rates were also similar (CD 46%; UC 50%). These findings show that carcinomas complicating CD and UC have strikingly similar clinicopathological features and suggest that a common underlying process, such as chronic inflammation, maybe important in the pathogenesis of colorectal carcinoma.

Full text

PDF
950

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atwell J. D., Duthie H. L., Goligher J. C. The outcome of Crohn's disease. Br J Surg. 1965 Dec;52(12):966–972. doi: 10.1002/bjs.1800521214. [DOI] [PubMed] [Google Scholar]
  2. Binder V. Epidemiology, course and socio-economic influence of inflammatory bowel disease. Schweiz Med Wochenschr. 1988 May 21;118(20):738–742. [PubMed] [Google Scholar]
  3. Both H., Torp-Pedersen K., Kreiner S., Hendriksen C., Binder V. Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group. Scand J Gastroenterol. 1983 Oct;18(7):987–991. doi: 10.3109/00365528309182127. [DOI] [PubMed] [Google Scholar]
  4. Camilleri M., Proano M. Advances in the assessment of disease activity in inflammatory bowel disease. Mayo Clin Proc. 1989 Jul;64(7):800–807. doi: 10.1016/s0025-6196(12)61753-4. [DOI] [PubMed] [Google Scholar]
  5. Chalifoux L. V., Bronson R. T. Colonic adenocarcinoma associated with chronic colitis in cotton top marmosets, Saguinus oedipus. Gastroenterology. 1981 May;80(5 Pt 1):942–946. [PubMed] [Google Scholar]
  6. Choi P. M., Nugent F. W., Schoetz D. J., Jr, Silverman M. L., Haggitt R. C. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993 Aug;105(2):418–424. doi: 10.1016/0016-5085(93)90715-o. [DOI] [PubMed] [Google Scholar]
  7. Choi P. M. Predominance of rectosigmoid neoplasia in ulcerative colitis and its implication on cancer surveillance. Gastroenterology. 1993 Feb;104(2):666–667. doi: 10.1016/0016-5085(93)90455-l. [DOI] [PubMed] [Google Scholar]
  8. Collins R. H., Jr, Feldman M., Fordtran J. S. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med. 1987 Jun 25;316(26):1654–1658. doi: 10.1056/NEJM198706253162609. [DOI] [PubMed] [Google Scholar]
  9. Cooper D. J., Weinstein M. A., Korelitz B. I. Complications of Crohn's disease predisposing to dysplasia and cancer of the intestinal tract: considerations of a surveillance program. J Clin Gastroenterol. 1984 Jun;6(3):217–224. [PubMed] [Google Scholar]
  10. Corman M. L., Veidenheimer M. C., Coller J. A. Colorectal carcinoma: a decade of experience at the Lahey Clinic. Dis Colon Rectum. 1979 Oct;22(7):477–479. doi: 10.1007/BF02586935. [DOI] [PubMed] [Google Scholar]
  11. Darke S. G., Parks A. G., Grogono J. L., Pollock D. J. Adenocarcinoma and Crohn's disease. A report of 2 cases and analysis of the literature. Br J Surg. 1973 Mar;60(3):169–175. doi: 10.1002/bjs.1800600302. [DOI] [PubMed] [Google Scholar]
  12. De Dombal F. T., Watts J. M., Watkinson G., Goligher J. C. Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum. Br Med J. 1966 Jun 11;1(5501):1442–1447. doi: 10.1136/bmj.1.5501.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Devroede G. J., Taylor W. F., Sauer W. G., Jackman R. J., Stickler G. B. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med. 1971 Jul 1;285(1):17–21. doi: 10.1056/NEJM197107012850103. [DOI] [PubMed] [Google Scholar]
  14. EDWARDS F. C., TRUELOVE S. C. THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS. Gut. 1964 Feb;5:1–22. doi: 10.1136/gut.5.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ekbom A., Helmick C., Zack M., Adami H. O. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990 Aug 11;336(8711):357–359. doi: 10.1016/0140-6736(90)91889-i. [DOI] [PubMed] [Google Scholar]
  16. Ekbom A., Helmick C., Zack M., Adami H. O. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990 Nov 1;323(18):1228–1233. doi: 10.1056/NEJM199011013231802. [DOI] [PubMed] [Google Scholar]
  17. Farmer R. G., Hawk W. A., Turnbull R. B., Jr Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology. 1975 Apr;68(4 Pt 1):627–635. [PubMed] [Google Scholar]
  18. Greenstein A. J., Sachar D. B., Smith H., Pucillo A., Papatestas A. E., Kreel I., Geller S. A., Janowitz H. D., Aufses A. H., Jr Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology. 1979 Aug;77(2):290–294. [PubMed] [Google Scholar]
  19. Hamilton S. R. Colorectal carcinoma in patients with Crohn's disease. Gastroenterology. 1985 Aug;89(2):398–407. doi: 10.1016/0016-5085(85)90343-9. [DOI] [PubMed] [Google Scholar]
  20. Hardy D. G., Youngs G. R. Crohn's disease and carcinoma of the rectum. Int Surg. 1972 Jun;57(6):504–506. [PubMed] [Google Scholar]
  21. Jones J. H. Colonic cancer and Crohn's disease. Gut. 1969 Aug;10(8):651–654. doi: 10.1136/gut.10.8.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kewenter J., Ahlman H., Hultén L. Cancer risk in extensive ulcerative colitis. Ann Surg. 1978 Dec;188(6):824–828. doi: 10.1097/00000658-197812000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kipping T. A., Rowntree T. Crohn's disease of the colon with carcinoma of the rectum. Proc R Soc Med. 1970 Aug;63(8):753–753. [PMC free article] [PubMed] [Google Scholar]
  24. Korelitz B. I., Lauwers G. Y., Sommers S. C. Rectal mucosal dysplasia in Crohn's disease. Gut. 1990 Dec;31(12):1382–1386. doi: 10.1136/gut.31.12.1382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kvist N., Jacobsen O., Nørgaard P., Ockelmann H. H., Kvist H. K., Schou G., Jarnum S. Malignancy in Crohn's disease. Scand J Gastroenterol. 1986 Jan;21(1):82–86. doi: 10.3109/00365528609034627. [DOI] [PubMed] [Google Scholar]
  26. Labayle D., Fischer D., Vielh P., Drouhin F., Pariente A., Bories C., Duhamel O., Trousset M., Attali P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology. 1991 Sep;101(3):635–639. doi: 10.1016/0016-5085(91)90519-q. [DOI] [PubMed] [Google Scholar]
  27. Löfberg R., Broström O., Karlén P., Ost A., Tribukait B. Carcinoma and DNA aneuploidy in Crohn's colitis--a histological and flow cytometric study. Gut. 1991 Aug;32(8):900–904. doi: 10.1136/gut.32.8.900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. MACDOUGALL I. P. THE CANCER RISK IN ULCERATIVE COLITIS. Lancet. 1964 Sep 26;2(7361):655–658. doi: 10.1016/s0140-6736(64)92474-2. [DOI] [PubMed] [Google Scholar]
  29. MARTINELLI V., BELLUCCI M. [Terminal ileitis and cancer of the right colon. (Presentation of a clinical case)]. Ann Ital Chir. 1959;36:557–572. [PubMed] [Google Scholar]
  30. Mann N. S., Tsai M. F., Nair P. K. Barrett's esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol. 1989 Dec;84(12):1494–1496. [PubMed] [Google Scholar]
  31. Narisawa T., Satoh M., Sano M., Takahashi T. Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin. Carcinogenesis. 1983 Oct;4(10):1225–1227. doi: 10.1093/carcin/4.10.1225. [DOI] [PubMed] [Google Scholar]
  32. Perrett A. D., Truelove S. C., Massarella G. R. Crohn's disease and carcinoma of colon. Br Med J. 1968 May 25;2(5603):466–468. doi: 10.1136/bmj.2.5603.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Petras R. E., Mir-Madjlessi S. H., Farmer R. G. Crohn's disease and intestinal carcinoma. A report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology. 1987 Dec;93(6):1307–1314. [PubMed] [Google Scholar]
  34. Pollard M., Luckert P. H. Treatment of chemically-induced intestinal cancers with indomethacin. Proc Soc Exp Biol Med. 1981 Jun;167(2):161–164. doi: 10.3181/00379727-167-41142. [DOI] [PubMed] [Google Scholar]
  35. Pozharisski K. M. The significance of nonspecific injury for colon carcinogenesis in rats. Cancer Res. 1975 Dec;35(12):3824–3830. [PubMed] [Google Scholar]
  36. ROSENQVIST H., OHRLING H., LAGERCRANTZ R., EDLING N. Ulcerative colitis and carcinoma coli. Lancet. 1959 May 2;1(7079):906–908. doi: 10.1016/s0140-6736(59)91308-x. [DOI] [PubMed] [Google Scholar]
  37. Ribeiro M. B., Greenstein A. J., Heimann T. M., Yamazaki Y., Aufses A. H., Jr Adenocarcinoma of the small intestine in Crohn's disease. Surg Gynecol Obstet. 1991 Nov;173(5):343–349. [PubMed] [Google Scholar]
  38. Richards M. E., Rickert R. R., Nance F. C. Crohn's disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease. Ann Surg. 1989 Jun;209(6):764–773. doi: 10.1097/00000658-198906000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rigau J., Piqué J. M., Rubio E., Planas R., Tarrech J. M., Bordas J. M. Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med. 1991 Dec 15;115(12):952–954. doi: 10.7326/0003-4819-115-12-952. [DOI] [PubMed] [Google Scholar]
  40. Roberts P. L., Veidenheimer M. C., Cassidy S., Silverman M. L. Adenocarcinoma arising in an ileostomy. Report of two cases and review of the literature. Arch Surg. 1989 Apr;124(4):497–499. doi: 10.1001/archsurg.1989.01410040107025. [DOI] [PubMed] [Google Scholar]
  41. Rosenberg L., Palmer J. R., Zauber A. G., Warshauer M. E., Stolley P. D., Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 1991 Mar 6;83(5):355–358. doi: 10.1093/jnci/83.5.355. [DOI] [PubMed] [Google Scholar]
  42. Sackett D. L., Whelan G. Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis. Gastroenterology. 1980 Jun;78(6):1632–1635. [PubMed] [Google Scholar]
  43. Savoca P. E., Ballantyne G. H., Cahow C. E. Gastrointestinal malignancies in Crohn's disease. A 20-year experience. Dis Colon Rectum. 1990 Jan;33(1):7–11. doi: 10.1007/BF02053192. [DOI] [PubMed] [Google Scholar]
  44. Simpson S., Traube J., Riddell R. H. The histologic appearance of dysplasia (precarcinomatous change) in Crohn's disease of the small and large intestine. Gastroenterology. 1981 Sep;81(3):492–501. [PubMed] [Google Scholar]
  45. Sporn M. B., Roberts A. B. Peptide growth factors and inflammation, tissue repair, and cancer. J Clin Invest. 1986 Aug;78(2):329–332. doi: 10.1172/JCI112580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Thayer W. R., Jr Crohn's disease (regional enteritis). A look at the last four years. Scand J Gastroenterol Suppl. 1970;6:165–185. [PubMed] [Google Scholar]
  47. Thun M. J., Namboodiri M. M., Heath C. W., Jr Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991 Dec 5;325(23):1593–1596. doi: 10.1056/NEJM199112053252301. [DOI] [PubMed] [Google Scholar]
  48. WEIN M. A., SPECTOR N., ROBINSON H. M. REGIONAL ILEITIS COMPLICATED BY ADENOCARCINOMA. REPORT OF A CASE. Am J Gastroenterol. 1964 Jan;41:58–63. [PubMed] [Google Scholar]
  49. Warren R., Barwick K. W. Crohn's colitis with carcinoma and dysplasia. Report of a case and review of 100 small and large bowel resections for Crohn's disease to detect incidence of dysplasia. Am J Surg Pathol. 1983 Mar;7(2):151–159. [PubMed] [Google Scholar]
  50. Weedon D. D., Shorter R. G., Ilstrup D. M., Huizenga K. A., Taylor W. F. Crohn's disease and cancer. N Engl J Med. 1973 Nov 22;289(21):1099–1103. doi: 10.1056/NEJM197311222892101. [DOI] [PubMed] [Google Scholar]
  51. Weitzman S. A., Gordon L. I. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood. 1990 Aug 15;76(4):655–663. [PubMed] [Google Scholar]
  52. Wyatt M. G., Houghton P. W., Mortensen N. J., Williamson R. C. The malignant potential of colorectal Crohn's disease. Ann R Coll Surg Engl. 1987 Sep;69(5):196–198. [PMC free article] [PubMed] [Google Scholar]
  53. Yamada M., Ohkusa T., Okayasu I. Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. Gut. 1992 Nov;33(11):1521–1527. doi: 10.1136/gut.33.11.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. de Leon M. L., Schoetz D. J., Jr, Coller J. A., Veidenheimer M. C. Colorectal cancer: Lahey Clinic experience, 1972-1976. An analysis of prognostic indicators. Dis Colon Rectum. 1987 Apr;30(4):237–242. doi: 10.1007/BF02556162. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES